Catestatin levels in acne patients
Treatments studied
Part of Skin clinical trials.
This trial measures a blood protein called catestatin in people with moderate to severe acne. It aims to understand how catestatin relates to acne, which may help guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate or severe acne (not mild acne)
- You are a healthy person overall
- You are not pregnant or breastfeeding
- You have not used oral acne medications in the last 4 weeks
- You have not used topical acne treatments in the last 2 weeks
- You have no history of chronic diseases such as liver, heart, or neurological problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a weekly dose of isotretinoin (a strong acne medicine) versus a standard tetracycline antibiotic for treating moderate acne. It aims to find a simpler, effective option with fewer side effects.
This study compares two doses of an acne pill called isotretinoin to see if a lower dose works as well as the standard dose with fewer side effects. If you have moderate to severe acne, this trial might help you find an effective treatment with less risk of side effects.
This study looks at how the bacteria on your face change when you take a medicine called isotretinoin for acne. It might help doctors understand why the medicine works and how to improve acne treatment.
This study looks at how a woman's natural hormone levels affect how well she responds to isotretinoin (a strong acne pill). It aims to help doctors predict which patients will benefit most from this treatment.
This trial compares oral isotretinoin (a strong acne medication) to standard treatments for people with moderate acne and darker skin tones. It aims to find which treatment works best for skin of color.
This study is looking at two substances in the blood (CXCL10 and CRP) that may be linked to how severe acne is. By measuring these levels, the study hopes to understand acne better and possibly find new ways to measure or treat it.
Hear when a new Acne Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.